Restoration Of Immune Balance With Anish Suri, Ph.D., President And CSO At Cue Biopharma
Source: Cell & Gene
Cue Biopharma's Anish Suri, Ph.D., explains why the clinical-stage biopharma is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the body to transform the treatment of cancer.
This website uses cookies to ensure you get the best experience on our website. Learn more